Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia
NCT00227942 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 86
Last updated 2014-05-26
Summary
This study will evaluate the effectiveness of estrogen replacement therapy in treating depression in menopausal women with hot flashes and insomnia.
Conditions
- Sleep Initiation and Maintenance Disorders
- Depression
Interventions
- DRUG
-
Estrogen Replacement Therapy
17-b-Estradiol Patch, .05 mg/day; applied for 7 days
- DRUG
-
Zolpidem
10 mg/day, po qhs
- DRUG
-
placebo
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
Hadine Joffe, MD
lead OTHER
Principal Investigators
-
Hadine Joffe, MD, MSC · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-08-31
- Completion
- 2007-11-30
Countries
- United States
Study Locations
More Related Trials
-
The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood
NCT03003949 ·Status: TERMINATED ·Phase: PHASE4
-
Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer
NCT00084669 ·Status: COMPLETED ·Phase: NA
-
Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
NCT03740009 ·Status: COMPLETED ·Phase: PHASE4
-
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
NCT00005768 ·Status: UNKNOWN ·Phase: PHASE2
-
Reducing the Experience of Menopausal Symptoms Through Temperature
NCT03937466 ·Status: COMPLETED ·Phase: NA
-
Aging and Estrogen on Cortical Function
NCT01268046 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
NCT00206622 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Quality in CHIMES (MF101)
NCT00454441 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
NCT01070979 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes
NCT00547001 ·Status: UNKNOWN ·Phase: NA
-
Early Menopause Hormone Treatment and Cognition
NCT01046643 ·Status: COMPLETED ·Phase: NA
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Raloxifene and Rimostil for Perimenopause-Related Depression
NCT00030147 ·Status: COMPLETED ·Phase: PHASE4
-
Postmenopausal Women Estrogen and Progesterone Infusion
NCT00455741 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
NCT00160342 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)
NCT00535288 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
NCT06049797 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)
NCT01015677 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Estrogen & Stress for Postmenopausal Women
NCT00220454 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
NCT00272935 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women
NCT00755963 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women
NCT00820664 ·Status: COMPLETED ·Phase: PHASE1
-
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
NCT04050592 ·Status: UNKNOWN ·Phase: PHASE4
-
A Definitive Estrogen Patch Study (ADEPT)
NCT00357006 ·Status: COMPLETED ·Phase: PHASE2